DailyDoctor Archive Specialties Get app
Back to the 25 October 2026 edition

Practice changer · 05 of 05

New overactive bladder drugs after BPH surgery: 6–11%, highest after laser vaporisation

Use procedure-specific figures of about 6–11% when counselling men about needing bladder medication after BPH surgery.

Design
Retrospective statewide claims cohort
Population
11,519 men without prior overactive bladder medication undergoing BPH surgery, 2017–2022
Primary outcome
New anticholinergic or beta-3 agonist fill 3–12 months after surgery
Effect
12-month incidence 5.7% (TUMT) to 11% (PVP); PVP vs TURP HR 1.49 (1.25–1.79)

This statewide claims study from Michigan identified 11,519 men who had BPH surgery between 2017 and 2022 and had never taken an anticholinergic or beta-3 agonist. It measured how many filled a new prescription for one between 3 and 12 months after surgery.

Twelve-month cumulative incidence ranged from 5.7% after microwave thermotherapy to 11% after laser photovaporisation. Compared with TURP, photovaporisation carried a higher hazard of starting medication (HR 1.49, 95% CI 1.25–1.79). Previous BPH medication and anticoagulant use were associated with higher risk, while being catheter-dependent before surgery was associated with lower risk.

Prescription fills are a proxy for bothersome storage symptoms, and the comparison between procedures is observational. But these are real-world, procedure-specific numbers a surgeon can quote, and they make counselling about post-operative storage symptoms concrete.

  • Quote a 6–11% chance of needing new bladder medication within a year, depending on procedure.
  • Mention the higher rate after laser photovaporisation when choosing a technique.
  • Flag men on anticoagulants or previous BPH drugs as higher risk for persistent storage symptoms.
  • Catheter-dependent men were less likely to need bladder medication afterwards.
  • Review storage symptoms at three months before attributing them to failed surgery.

Why it matters

It gives surgeons numbers instead of a vague warning when consenting for BPH procedures.

Don't overread it

Prescription claims, not symptom scores; differences between procedures may reflect patient selection.

The statistics, in plain English

An HR of 1.49 means about a 50% higher rate of starting medication after photovaporisation than after TURP. Because the baseline rates are around 6–11%, the absolute differences between procedures are a few percentage points.

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

bladdercancerbphprostatecancer

Tomorrow morning, before your first patient

One edition a day for urology, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free
Daily Doctor All 27 specialties, every morning. Free.
Get the app